Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Rocket
3201.0000 -54.70 (-1.68%)
NSE Jun 25, 2026 12:15 PM
Volume: 19,002
 

logo
Ajanta Pharma Ltd.
25 Jan 2017
3201.00
-1.68%
buy
Results Update: Ajanta Pharma Ltd.
by HDFC Securities
HDFC Securities
Revenue increased by 2.52% to Rs. 515.02 Cr in Q3FY17 when compared to the previous quarter. Also, it increased by 9.68% when compared with Q3FY16
 
Ajanta Pharma Ltd. has an average target of 3416.75 from 4 brokers.
More from Ajanta Pharma Ltd.
Recommended
Market trades higher, Route Mobile reports cybersecurity incident at South American arm
Trendlyne Marketwatch | 25 Jun 2026, 12:06PM
PSU stake sales in Q1FY27 have already raised nearly as much as all of FY26. What's driving the …
The Baseline | 25 Jun 2026, 11:24AM
Ajanta Pharma disputes ET article on FDA import alert
| 24 Jan 2017, 11:26AM